)
Visual
test
Embecta
Embecta (EMBC) investor relations material
Embecta Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary5 Feb, 2026
Executive summary
Completed transition to an independent company, advancing brand transition in North America and internationally, with substantial completion targeted by end of 2026.
Strengthened U.S. Medicare business with new and renewed exclusive contracts, supporting stable share.
Progressed product design and manufacturing for pen needles and syringes, and expanded B2B partnerships and GLP-1 packaging initiatives.
Paid down $37.5M of term loan B, reducing net leverage to 2.8x from 3.7x year-over-year.
Ongoing transformation to broaden product portfolio and adapt to evolving chronic care and drug delivery markets.
Financial highlights
Q1 FY26 revenue was $261.2M, down 0.3% year-over-year; adjusted constant currency revenue declined 2.0%.
U.S. revenue was $130.9M, down 7.6% year-over-year (adjusted constant currency); international revenue was $130.3M, up 8.4% reported and 4.6% adjusted constant currency.
Gross profit was $161.7M (61.9% margin), up from $157.1M (60.0%) last year; adjusted gross profit was $163.5M (62.6% margin), slightly down from $164.2M (62.7%).
Operating income was $83.3M (31.9% margin), up from $28.7M (11.0%) last year; adjusted operating income was $79.3M (30.4% margin), down from $80.5M (30.7%).
Net income was $44.1M ($0.74–$0.75 per diluted share), up from break-even last year; adjusted net income was $42.3M ($0.71 per share), up from $38.3M ($0.65).
Free cash flow for Q1 FY26 was $16.6M–$17M.
Outlook and guidance
FY26 reported revenue guidance: $1,071M–$1,093M, growth of (0.9)% to 1.1%, expected near the lower end.
Adjusted constant currency revenue growth expected between (2.0)% and 0.0%.
Adjusted operating margin guidance: 29.0%–30.0%; adjusted EPS: $2.80–$3.00, both expected near the lower end.
Anticipates $150M in debt repayment and $180–$200M in free cash flow for FY26, closer to the low end.
Interest expense expected at ~$93M; adjusted tax rate ~23%.
What specific market dynamics caused US revenue decline?
Expected revenue contribution from B2B partnerships?
What is the target for annual debt reduction?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebPECO
2026 FFO per share growth guided at 5.5% with record occupancy and robust acquisitions. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
- 6 FebEMBASSY
Record revenue, NOI, and distributions highlight strong growth and robust segment performance. - 6 FebCRIRevenue fell and losses deepened, but ESA contracts and R&D projects drive future prospects.
- 6 FebTUPRS
Net income reached TRY 29.5 billion, with strong dividends and a robust net cash position.
Next Embecta earnings date
Q2 20268 May, 2026
Embecta
Next Embecta earnings date
Q2 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Embecta Corp is a medical technology company focused on the development and manufacturing of diabetes care products. The company specializes in providing devices and solutions for insulin delivery, including insulin syringes and pen needles, aimed at improving the daily management of diabetes. Embecta serves healthcare providers and patients globally, with a mission to support individuals with diabetes in maintaining their health through reliable and accessible products. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage